Peer-influenced content. Sources you trust. No registration required. This is HCN.

Psychiatry AdvisorDextromethorphan-Bupropion Effective for Comorbid Anxiety, Major Depressive Disorder

Data from the open label Evaluation of NMDA Modulation for Depressive Episodes (EVOLVE) study presented at Psych Congress 2022 showed a significant decrease in HAM-A scores at 1 week, with further decreases in scores observed through 12 months.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form